MASCIARI, S., A. DEWANWALA, Elena M. STOFFEL, Gregory Y. LAUWERS, Hui ZHENG, Maria Isabel ACHATZ, Douglas RIEGERT-JOHNSON, Lenka FORETOVÁ, Edaise M. SILVA, Lisa DIGIANNI, Sigitas VERSELIS, Katherine SCHNEIDER, Frederick P. LI, Joseph FRAUMENI, Judy GARBER a Sapna SYNGAL. Gastric cancer in individuals with Li-Fraumeni syndrome. Genetics In Medicine. United States: Lippincott, Williams & Wilkins, 2011, roč. 13, č. 7, s. 651-657. ISSN 1098-3600. Dostupné z: https://dx.doi.org/10.1097/GIM.0b013e31821628b6.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Gastric cancer in individuals with Li-Fraumeni syndrome
Autoři MASCIARI, S. (840 Spojené státy, garant), A. DEWANWALA (840 Spojené státy), Elena M. STOFFEL (840 Spojené státy), Gregory Y. LAUWERS (840 Spojené státy), Hui ZHENG (840 Spojené státy), Maria Isabel ACHATZ (840 Spojené státy), Douglas RIEGERT-JOHNSON (840 Spojené státy), Lenka FORETOVÁ (203 Česká republika, domácí), Edaise M. SILVA (76 Brazílie), Lisa DIGIANNI (840 Spojené státy), Sigitas VERSELIS (840 Spojené státy), Katherine SCHNEIDER (840 Spojené státy), Frederick P. LI (840 Spojené státy), Joseph FRAUMENI (840 Spojené státy), Judy GARBER (840 Spojené státy) a Sapna SYNGAL (840 Spojené státy).
Vydání Genetics In Medicine, United States, Lippincott, Williams & Wilkins, 2011, 1098-3600.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30200 3.2 Clinical medicine
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 4.762
Kód RIV RIV/00216224:14110/11:00055281
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1097/GIM.0b013e31821628b6
UT WoS 000292538200008
Klíčová slova anglicky Li Fraumeni syndrome; gastric cancer; hereditary gastric cancer syndromes; germline mutations; TP53
Příznaky Mezinárodní význam
Změnil Změnil: Mgr. Michal Petr, učo 65024. Změněno: 2. 2. 2012 09:25.
Anotace
Li-Fraumeni syndrome is a rare hereditary cancer syndrome associated with germline mutations in the TP53 gene. Although sarcomas, brain tumors, leukemias, breast and adrenal cortical carcinomas are typically recognized as Li-Fraumeni syndrome-associated tumors, the occurrence of gastrointestinal neoplasms has not been fully evaluated. In this analysis, we investigated the frequency and characteristics of gastric cancer in Li-Fraumeni syndrome. Methods: Pedigrees and medical records of 62 TP53 mutation-positive families were retrospectively reviewed from the Dana-Farber/National Cancer Institute Li-Fraumeni syndrome registry. We identified subjects with gastric cancer documented either by pathology report or death certificate and performed pathology review of the available specimens. Results: Among 62 TP53 mutation-positive families, there were 429 cancer-affected individuals. Gastric cancer was the diagnosis in the lineages of 21 (4.9%) subjects from 14 families (22.6%). The mean and median ages at gastric cancer diagnosis were 43 and 36 years, respectively (range: 24-74 years), significantly younger compared with the median age at diagnosis in the general population based on Surveillance Epidemiology and End Results data (71 years). Five (8.1%) families reported two or more cases of gastric cancer, and six (9.7%) families had cases of both colorectal and gastric cancers. No association was seen between phenotype and type/location of the TP53 mutations. Pathology review of the available tumors revealed both intestinal and diffuse histologies. Conclusions: Early-onset gastric cancer seems to be a component of Li-Fraumeni syndrome, suggesting the need for early and regular endoscopic screening in individuals with germline TP53 mutations, particularly among those with a family history of gastric cancer
VytisknoutZobrazeno: 25. 4. 2024 17:42